Corient Private Wealth LLC Has $18.82 Million Holdings in STERIS plc (NYSE:STE)

Corient Private Wealth LLC lessened its holdings in shares of STERIS plc (NYSE:STE) by 9.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 91,528 shares of the medical equipment provider’s stock after selling 9,647 shares during the quarter. Corient Private Wealth LLC’s holdings in STERIS were worth $18,815,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in STE. Raymond James Financial Inc. acquired a new stake in STERIS during the 4th quarter worth $223,987,000. Franklin Resources Inc. raised its stake in STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares during the period. Boston Trust Walden Corp raised its stake in STERIS by 400.4% during the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock worth $46,198,000 after buying an additional 179,829 shares during the period. Swedbank AB acquired a new stake in STERIS during the 3rd quarter worth $28,251,000. Finally, Benjamin Edwards Inc. raised its stake in STERIS by 2,123.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock worth $27,574,000 after buying an additional 108,559 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Piper Sandler increased their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens reiterated an “overweight” rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Price Performance

Shares of NYSE STE opened at $228.29 on Wednesday. The stock has a market capitalization of $22.43 billion, a price-to-earnings ratio of 48.47 and a beta of 0.92. The business has a 50-day moving average of $220.09 and a 200-day moving average of $222.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, sell-side analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s payout ratio is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.